EA201792083A1 - ATTENUATED GRIPPOSOUS VECTORS FOR PREVENTION AND / OR TREATING INFECTIOUS DISEASES, AND ALSO FOR TREATING ONCOLOGICAL DISEASES - Google Patents

ATTENUATED GRIPPOSOUS VECTORS FOR PREVENTION AND / OR TREATING INFECTIOUS DISEASES, AND ALSO FOR TREATING ONCOLOGICAL DISEASES

Info

Publication number
EA201792083A1
EA201792083A1 EA201792083A EA201792083A EA201792083A1 EA 201792083 A1 EA201792083 A1 EA 201792083A1 EA 201792083 A EA201792083 A EA 201792083A EA 201792083 A EA201792083 A EA 201792083A EA 201792083 A1 EA201792083 A1 EA 201792083A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treating
diseases
attenuated
prevention
gripposous
Prior art date
Application number
EA201792083A
Other languages
Russian (ru)
Other versions
EA037571B1 (en
Inventor
Андрей Юрьевич ЕГОРОВ
Борис ФЕРКО
Артем Александрович КРОХИН
Юлия Романовна РОМАНОВА
Original Assignee
Общество с ограниченной ответственностью "ФАРМИНТЕРПРАЙСЕЗ БИОТЕХ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2015147703A external-priority patent/RU2628690C2/en
Priority claimed from RU2016111907A external-priority patent/RU2660562C2/en
Application filed by Общество с ограниченной ответственностью "ФАРМИНТЕРПРАЙСЕЗ БИОТЕХ" filed Critical Общество с ограниченной ответственностью "ФАРМИНТЕРПРАЙСЕЗ БИОТЕХ"
Publication of EA201792083A1 publication Critical patent/EA201792083A1/en
Publication of EA037571B1 publication Critical patent/EA037571B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к области медицины и вирусологии. Представлены аттенуированные вирусы гриппа А, гриппозные векторы на их основе и содержащие их фармацевтические композиции, которые могут применяться для профилактики и/или лечения инфекционных заболеваний. Дополнительно, настоящее изобретение относится к аттенуированным вирусам гриппа А, гриппозным векторам на их основе и содержащим их фармацевтическим композиция, которые могут применяться для лечения онкологических заболеваний.The present invention relates to the field of medicine and virology. Attenuated influenza A viruses, influenza vectors based on them, and pharmaceutical compositions containing them, which can be used for the prevention and / or treatment of infectious diseases, are presented. Additionally, the present invention relates to attenuated influenza A viruses, influenza vectors based on them, and a pharmaceutical composition containing them, which can be used to treat cancer diseases.

EA201792083A 2015-11-06 2016-11-03 Attenuated influenza a virus, attenuated influenza vector, pharmaceutical composition and use thereof in the prevention or treatment of infectious diseases and for the treatment of oncological diseases EA037571B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2015147703A RU2628690C2 (en) 2015-11-06 2015-11-06 Attenuated influenza vectors for the prevention and/or treatment of infectious diseases, as well as for cancer treatment
RU2016111907A RU2660562C2 (en) 2016-03-30 2016-03-30 Attenuated grippose vector and mucosal universal grippose vaccine on its basis
PCT/RU2016/050066 WO2017078577A2 (en) 2015-11-06 2016-11-03 Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Publications (2)

Publication Number Publication Date
EA201792083A1 true EA201792083A1 (en) 2018-07-31
EA037571B1 EA037571B1 (en) 2021-04-15

Family

ID=62748489

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201792083A EA037571B1 (en) 2015-11-06 2016-11-03 Attenuated influenza a virus, attenuated influenza vector, pharmaceutical composition and use thereof in the prevention or treatment of infectious diseases and for the treatment of oncological diseases

Country Status (3)

Country Link
CL (1) CL2018001201A1 (en)
EA (1) EA037571B1 (en)
ZA (1) ZA201803649B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1085904B1 (en) * 1998-06-12 2012-11-28 Mount Sinai School of Medicine Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
WO2001064860A2 (en) * 2000-03-02 2001-09-07 Polymun Scientific Immunbiologische Forschung Gmbh Recombinant influenza a viruses
US7037707B2 (en) * 2003-09-04 2006-05-02 St. Jude Children's Research Hospital Method for generating influenza viruses and vaccines

Also Published As

Publication number Publication date
EA037571B1 (en) 2021-04-15
CL2018001201A1 (en) 2018-09-21
ZA201803649B (en) 2019-11-27

Similar Documents

Publication Publication Date Title
EA201790700A1 (en) MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES
CY1121874T1 (en) Mono- or Disubstituted Indole Derivatives as Dengue Virus Replication Inhibitors
ECSP17073878A (en) DERIVED FROM INDOL MONO OR DISUSTITUTED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE
EA201691261A1 (en) NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS
EA201691726A1 (en) NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
CY1122792T1 (en) MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS
EA201690306A1 (en) IDO INHIBITORS
EA201690152A1 (en) IDO INHIBITORS
EA201591599A1 (en) IDO INHIBITORS
EA201791614A1 (en) INDOL DERIVATIVES AS AN INHIBITORS OF DENGE VIRUS REPLICATION
EA201992784A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201791916A1 (en) 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT
MX2022000453A (en) Compounds useful to treat influenza virus infections.
MX2017015462A (en) Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases.
EA201892216A1 (en) SUBSTITUTED INDIN DERIVATIVES AS AN INHIBITORS OF DENG VIRUS REPLICATION
EA201992782A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201890722A1 (en) Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication
EA201590703A1 (en) MEK INHIBITORS FOR TREATING VIRAL DISEASES
EA201692358A1 (en) IZOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTION
MX2019004029A (en) Compounds and methods for diagnosis and treatment of viral infections.
EA201990988A1 (en) ANTIBODIES AGAINST CHIKV AND WAYS OF THEIR APPLICATION
EA201790776A1 (en) COMBINED COMPOSITIONS OF LONG-TERM ACTIONS AND METHODS OF TREATING HEPATITIS C
EA201790771A1 (en) PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FOR THE TREATMENT OF HEPATITIS C
PH12017501943B1 (en) Influenza virus neutralizing peptidomimetic compounds
EA201792083A1 (en) ATTENUATED GRIPPOSOUS VECTORS FOR PREVENTION AND / OR TREATING INFECTIOUS DISEASES, AND ALSO FOR TREATING ONCOLOGICAL DISEASES